Status:
UNKNOWN
The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial
Lead Sponsor:
Third Affiliated Hospital of Zhengzhou University
Conditions:
Induced Abortion
Anesthesia
Eligibility:
All Genders
20-35 years
Phase:
PHASE4
Brief Summary
To explore the feasibility of different doses of etomidate admixed with propofol in induced abortion: a randomized, double blind controlled trial.
Eligibility Criteria
Inclusion
- Aged between 20 and 35 years
- American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ
- Singleton pregnancy and the gestational period is 6 to 8 weeks
- Expected operation duration is within 60 minutes
- The body weight should be within 15% around the standard weight
- Signed informed consent form
Exclusion
- Serious cardiac, cerebral, liver, kidney, lung, endocrine disease
- Upper respiratory infections within 4 weeks
- Long use of hormone or history of adrenal suppression
- History of use of glucocorticoids, aprotinin or immunosuppressant
- Manifestation of immunodeficiency
- History of use of sedatives or opiates
- Needs of Neuromuscular blocker (except intubation)
- Allergy to trial drug or other contraindication
- Pregnant or breast-feeding women
- Attended other trial past 30 days
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02208596
Start Date
September 1 2014
End Date
February 1 2015
Last Update
August 5 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.